1. Symptoms, adverse effects and complications associated with dobutamine stress echocardiography. Experience in 1118 patients;Mertes, H.; Sawada, S.G.; Ryan, T.; Segar, D.S.; Kovacs, R.; Foltz, J.;Circulation,1993
2. Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease;Poldermans, D.; Fioretti, P.M.; Boersma, E.; Forster, T.; van Urk, H.; Comel, J.H.;Am J Cardiol,1994
3. Dobutamine versus dipyridamole echocardiography in coronary artery disease;Previtali, M.; Lanzarini, L.; Ferrario, M.; Tortorici, M.; Mussini, A.; Montemartini, C.;Circulation,1991
4. Clinical significance of abrupt vasodepression during dobutamine stress echocardiography;Mazeika, P.K.; Nadazdin, A.; Oakley, C.M.;Am J Cardiol,1992
5. Comparison of dobutamine stress echocardiography, dipyridamole stress echocardiography and exercise stress testing for diagnosis of coronary artery disease;Previtali, M.; Lanzarini, L.; Fetiveau, R.; Poli, A.; Ferrario, M.; Falcone, C.; Mussini, A.;Am Y Cardiol,1993